乳腺癌患者第二原发肺癌与肺转移的临床病理特征
回顾性分析55例乳腺癌合并第二原发肺癌与205例乳腺癌孤立性肺转移患者的临床病理资料,发现第二原发肺癌占乳腺癌肺部恶性孤立性结节的21.2%,多因素分析显示年龄、乳腺肿瘤大小和放疗史为独立相关因素。
要点
- 乳腺癌合并第二原发肺癌占肺部恶性孤立性结节的21.2%,占全部乳腺癌的0.84%。
- 高龄、乳腺肿瘤较大和放疗史是第二原发肺癌的独立相关因素。
- 对乳腺癌患者肺部孤立性结节应及时行组织病理学检查以鉴别原发与转移。
核心结论
- 乳腺癌患者肺部孤立性结节需鉴别第二原发肺癌与肺转移,尤其高龄、肿瘤较大和放疗史者。
研究设计与样本
- 回顾性分析2006年1月至2017年1月山东省肿瘤医院55例乳腺癌合并第二原发肺癌和205例乳腺癌孤立性肺转移患者。
主要发现
- 第二原发肺癌占乳腺癌肺部恶性孤立性结节的21.2%(55/260),占同期乳腺癌的0.84%(55/6 580)。
- 乳腺癌手术至确诊第二原发肺癌和肺转移的中位间隔分别为52个月和42个月。
- 两组在年龄、间隔时间、乳腺肿瘤大小、腋窝淋巴结转移、雌激素受体、分子分型(Luminal B型和三阴性型)和放疗史上差异有统计学意义(均P<0.05)。
- 多因素logistic回归显示年龄(OR=1.088,P<0.001)、乳腺肿瘤大小(OR=0.480,P<0.001)和放疗史(OR=3.460,P=0.004)为第二原发肺癌的独立相关因素。
临床怎么用
- 对乳腺癌患者肺部孤立性结节应警惕第二原发肺癌可能,及时行组织病理学检查。
- 第二原发肺癌与肺转移的治疗方案完全不同,需明确诊断后制定治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To compare the clinicopathological characteristics of second primary lung cancer following breast cancer and lung metastases from breast cancer, and then to analyze the risk factors in breast cancer patients with second primary lung tumor. Methods: Clinical data of 55 breast cancer patients with second primary lung tumor and 205 breast cancer patients with solitary pulmonary metastasis in Shandong Cancer Hospital from January 2006 to January 2017 were retrospectively analyzed. The risk factors of primary lung cancer following breast cancer were analyzed using logistic regression model. Results: Second primary lung cancer in patients with first breast cancer accounted for approximately 21.2%(55/260) of pulmonary malignant solitary nodules, and 0.84%(55/6 580) of all breast cancer patients. The median intervals between the diagnosis of second primary lung cancer or lung metastasis and first breast cancer were 52 months and 42 months, respectively. These two groups showed significant difference between age, time interval between diagnoses, breast tumor size, axillary lymph node metastasis, estrogen receptor, molecular subtype (luminal B and triple-negative) and history of radiotherapy (P<0.05 for all). A multivariate logistic regression model confirmed that age (OR=1.088, P<0.001), breast tumor size(OR=0.480, P<0.001), and radiotherapy history (OR=3.460, P=0.004) were all independent factors for second primary lung cancer. Conclusions: For isolated pulmonary nodules in patients with breast cancer, especially for those with elder age, larger tumor size and radiotherapy history, we should distinguish the second primary lung cancer from pulmonary metastasis. The treatment regimen for lung metastasis and primary lung cancer in patients with breast cancer are entirely distinct. The timely histopathology examinations for pulmonary nodes in patients with breast cancer are recommended. 目的: 探讨乳腺癌合并原发性肺癌以及乳腺癌肺转移患者的临床病理特征,并分析乳腺癌合并原发性肺癌的疾病相关因素。 方法: 回顾性分析2006年1月至2017年1月经山东省肿瘤医院病理证实的55例原发性乳腺癌合并原发性孤立性肺癌患者的临床病理资料,与同期收治的205例乳腺癌孤立性肺转移患者进行比较,并对乳腺癌合并原发性肺癌的相关因素进行logistic回归分析。 结果: 乳腺癌合并原发性肺癌占乳腺癌肺部恶性孤立性结节的21.2%(55/260),占同期乳腺癌的0.84%(55/6 580)。乳腺癌手术至确诊原发性肺癌和乳腺癌孤立性肺转移的中位间隔时间分别为52个月和42个月。乳腺癌合并原发性肺癌组患者的发病年龄、间隔时间、乳腺肿瘤大小、腋窝淋巴结转移数目、雌激素受体状态、分子分型(Luminal B型和三阴性型)和放疗史与乳腺肺转移癌组比较,差异有统计学意义(均P<0.05)。多因素回归分析结果显示,乳腺癌患者的发病年龄(P<0.001)、乳腺肿瘤大小(P<0.001)和放疗史(P=0.004)与乳腺癌合并原发性肺癌有关。 结论: 对于乳腺癌患者合并的肺部孤立性结节,不能只考虑乳腺癌肺转移,要考虑到乳腺癌合并原发性肺癌的可能,尤其是高龄、乳腺肿瘤较大和有放疗史者。乳腺癌合并原发性肺癌与乳腺癌肺转移的处理原则不同,必要时应对乳腺癌合并的肺部占位及时进行组织病理学检查。.
引用
- He KW, Wei W, Liu ZY, et al. [Clinicopathological features of second primary lung cancer and pulmonary metastasisin patients with breast cancer]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29575839. doi:10.3760/cma.j.issn.0253-3766.2018.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。